Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

10.93B

Market cap10.93B

Price-Earnings ratio

-3.05

Price-Earnings ratio-3.05

Dividend yield

—

Dividend yield—

Average volume

8.61M

Average volume8.61M

High today

$30.27

High today$30.27

Low today

$26.11

Low today$26.11

Open price

$28.89

Open price$28.89

Volume

20.46M

Volume20.46M

52 Week high

$170.47

52 Week high$170.47

52 Week low

$26.11

52 Week low$26.11

MRNA News

Sherwood News 8h

S&P 500 turns massive losses into solid gain

S&P 500 turns massive losses into solid gain It was shaping up just like Thursday and Friday — a tumble in AI darlings leading the market down — until it wasn’...

Benzinga 15h

Moderna, Novavax Shares Are Tumbling Monday: What's Going On?

Vaccine stocks are trading lower Monday following a shakeup at the U.S. Food and Drug Administration. What Happened: Peter Marks has resigned from his role at...

Sherwood News 16h

Moderna stock drops after FDA vaccine chief resigns

Moderna stock drops after FDA vaccine chief resigns Moderna shares fell 10% in premarket trading Monday morning after reports that the Food and Drug Administra...

Analyst ratings

68%

of 28 ratings

Buy

17.9%

Hold

67.9%

Sell

14.3%